Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Moreaux

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Expert Review of Hematology|January 14, 2016
Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapyCaroline Bret, Elena Viziteu, Alboukadel Kassambara, et al.
Biomarker Research|February 16, 2016
RECQ helicases are deregulated in hematological malignancies in association with a prognostic valueElena Viziteu, Alboukadel Kassambara, Philippe Pasero, et al.
International Journal of Molecular Sciences|October 31, 2020
Role of Polycomb Complexes in Normal and Malignant Plasma CellsEmmanuel Varlet, Sara Ovejero, Anne-Marie Martinez, et al.
Leukemia|February 14, 2019
EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiationLaurie Herviou, Michel Jourdan, Anne-Marie Martinez, et al.
British Journal of Haematology|November 15, 2013
DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidineJerome Moreaux, Angelique Bruyer, Jean-Luc Veyrune, et al.
British Journal of Cancer|February 12, 2016
Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myelomaElena Viziteu, Camille Grandmougin, Hartmut Goldschmidt, et al.
Experimental Hematology|September 22, 2010
MYEOV is a prognostic factor in multiple myelomaJerome Moreaux, Dirk Hose, Amélie Bonnefond, et al.
Haematologica|April 16, 2013
Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myelomaMatthieu Schoenhals, Alboukadel Kassambara, Jean-Luc Veyrune, et al.
Blood|November 25, 2010
Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migrationJerome Moreaux, Dirk Hose, Alboukadel Kassambara, et al.
International Journal of Hematology|September 5, 2003
Survival and proliferation factors of normal and malignant plasma cellsBernard Klein, Karin Tarte, Michel Jourdan, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Expert Review of Hematology|January 14, 2016
Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapyCaroline Bret, Elena Viziteu, Alboukadel Kassambara, et al.
Biomarker Research|February 16, 2016
RECQ helicases are deregulated in hematological malignancies in association with a prognostic valueElena Viziteu, Alboukadel Kassambara, Philippe Pasero, et al.
International Journal of Molecular Sciences|October 31, 2020
Role of Polycomb Complexes in Normal and Malignant Plasma CellsEmmanuel Varlet, Sara Ovejero, Anne-Marie Martinez, et al.
Leukemia|February 14, 2019
EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiationLaurie Herviou, Michel Jourdan, Anne-Marie Martinez, et al.
British Journal of Haematology|November 15, 2013
DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidineJerome Moreaux, Angelique Bruyer, Jean-Luc Veyrune, et al.
British Journal of Cancer|February 12, 2016
Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myelomaElena Viziteu, Camille Grandmougin, Hartmut Goldschmidt, et al.
Experimental Hematology|September 22, 2010
MYEOV is a prognostic factor in multiple myelomaJerome Moreaux, Dirk Hose, Amélie Bonnefond, et al.
Haematologica|April 16, 2013
Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myelomaMatthieu Schoenhals, Alboukadel Kassambara, Jean-Luc Veyrune, et al.
Blood|November 25, 2010
Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migrationJerome Moreaux, Dirk Hose, Alboukadel Kassambara, et al.
International Journal of Hematology|September 5, 2003
Survival and proliferation factors of normal and malignant plasma cellsBernard Klein, Karin Tarte, Michel Jourdan, et al.
Pageof 4